VanEck selects SOL Strategies as the staking provider for its new Solana ETF (VSOL), highlighting SOL Strategies’ certified infrastructure. SOL Strategies has been selected as the staking provider for the VanEck Solana ETF. This partnership comes in the face of rising demand for institutional-grade, high-performance, and compliant Solana staking. SOL Strategies’ infrastructure of ISO 27001 […] The post Solana News: VanEck Taps SOL Strategies to Stake Its Solana ETF appeared first on Live Bitcoin News.VanEck selects SOL Strategies as the staking provider for its new Solana ETF (VSOL), highlighting SOL Strategies’ certified infrastructure. SOL Strategies has been selected as the staking provider for the VanEck Solana ETF. This partnership comes in the face of rising demand for institutional-grade, high-performance, and compliant Solana staking. SOL Strategies’ infrastructure of ISO 27001 […] The post Solana News: VanEck Taps SOL Strategies to Stake Its Solana ETF appeared first on Live Bitcoin News.

Solana News: VanEck Taps SOL Strategies to Stake Its Solana ETF

VanEck selects SOL Strategies as the staking provider for its new Solana ETF (VSOL), highlighting SOL Strategies’ certified infrastructure.

SOL Strategies has been selected as the staking provider for the VanEck Solana ETF. This partnership comes in the face of rising demand for institutional-grade, high-performance, and compliant Solana staking. SOL Strategies’ infrastructure of ISO 27001 & SOC 2 certified infrastructure is poised to scale with this demand.

SOL Strategies: Wall Street’s Gateway to Solana Staking

VanEck has always been an advocate of the Solana ecosystem. This selection represents a continuation of the validation of the staking infrastructure platform of SOL Strategies. It also reinforces their thesis as a Solana Economy Company.

This is a continuation of the previous work of SOL Strategies. This includes both the validator infrastructure and the staking services. It emphasizes their dedication to a value-creating future. This value is much more than a mere treasury. It further strengthens their position as “Wall Street’s Gateway to Solana.”

Related Reading: Crypto News: Hong Kong Approves Asia’s First Solana ETF as Analysts Target $400 | Live Bitcoin News

SOL Strategies has been chosen as the staking service provider for VanEck’s newly debuted Solana ETF (VSOL). SOL Strategies is a Canadian investment company. It specializes in the Solana ecosystem. It also has a revenue-generating validator business.

More details about the partnership have been announced. SOL Strategies announced its selection on November 17, 2025. Their business model is to operate ISO 27001 and SOC 2 certified validators. They also provide strategic investments and infrastructure solutions. These are all in the Solana ecosystem.

Solana News: VanEck Taps SOL Strategies to Stake Its Solana ETFSource: X

A fee waiver is also part of the launch. VanEck is foregoing the sponsor fee for VSOL at launch. This is for the first $1 billion in assets under management (AUM). This waiver is to be extended to February 17, 2026. During this period, SOL Strategies will also waive their fee for their staking services. This provides an incentive to adopt early and reap the maximum return for initial investors.

Institutional-Grade Services and Ecosystem Validation

SOL Strategies offers institutional-grade services. Their institutional client base consists of partnerships with premier custodians. These custodians include Bitgo and Crypto.com. The company has also passed SOC 1, SOC 2 and ISO 27001 audits. These are applicable to its staking platform. This strict compliance shows their focus on security and reliability.

This partnership is a major development for the Solana ecosystem. It brings a new level of institutional sanction. The launch of a Solana ETF by a major player in the financial world such as VanEck, highlights the growing importance of Solana. The choice of SOL Strategies further demonstrates the need for secure and compliant staking solutions.

This important partnership is highly expected to attract a new breed of traditional investors towards the Solana blockchain, thereby gradually leading to more growth, adoption and innovation in the thriving ecosystem. It is a key moment in the continued convergence of traditional finance and decentralized digital assets. It will also create additional growth and adoption of its ecosystem.

The post Solana News: VanEck Taps SOL Strategies to Stake Its Solana ETF appeared first on Live Bitcoin News.

Market Opportunity
Solana Logo
Solana Price(SOL)
$142
$142$142
-1.04%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26